2 terminated. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 3 | 1 | Terminated 1 |
Follow BK Virus Infection: new trials by email Literature Review of BK Virus Infection trials Research Report on BK Virus Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation Brincidofovir - BK Virus Infection, Nephropathy | Phase 2 | Terminated | SymBio Pharmaceuticals | 1 | 2022-10-14 | 2024-12-04 |
| Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant Posoleucel (ALVR105), Placebo - Adenovirus Infection, BK Virus Infection | Phase 2 / Phase 3 | Terminated | AlloVir | 451 | 2022-03-24 | 2024-05-16 |
Adenoviridae Infections (1) · Cytomegalovirus Infections (1) · Epstein-Barr Virus Infections (1) · Kidney Diseases (1)
DNA Virus Infections (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Herpesviridae Infections (1) · Infections (1) · Male Urogenital Diseases (1) · Tumor Virus Infections (1) · Urogenital Diseases (1) · Urologic Diseases (1) · Virus Diseases (1)
brincidofovir (1)
AlloVir (1) · SymBio Pharmaceuticals (1)
Australia (1) · Belgium (1) · Canada (1) · France (1) · Italy (1) · Japan (1) · South Korea (1) · Spain (1) · Turkey (Türkiye) (1) · United Kingdom (1) · United States (1)